Related by context. All words. (Click for frequent words.) 73 carcinoma 73 malignancies 70 prostate cancers 69 cancers 69 malignant 68 tumors 68 metastases 67 metastatic disease 67 metastatic cancer 67 micrometastases 67 neoplasm 66 adenoma 66 adenocarcinoma 66 breast carcinomas 66 melanoma 66 distant metastases 66 prostate cancer CaP 66 metastatic 66 ovarian tumors 66 neoplasia 66 colorectal cancer 65 breast cancers 65 colorectal cancers 65 endometrial cancers 65 precursor lesions 65 neoplasms 65 GISTs 65 metastasis 65 PCa 65 tumor 64 bone metastasis 64 tumor recurrence 64 bladder cancers 64 carcinomas 64 malignant growths 64 colorectal carcinoma 64 premalignant lesions 64 lobular carcinoma 64 ovarian cancers 63 malignant tumors 63 gastric cancer 63 sarcoma 63 lymphomas 63 carcinoid tumor 63 colorectal tumors 63 prostate adenocarcinoma 63 anaplastic 63 DCIS 63 adenomatous polyps 63 hepatocellular carcinoma 63 ADPKD 63 oropharyngeal cancer 63 distant metastasis 63 renal cell carcinomas 62 pancreatic cancers 62 gastric cancers 62 glioblastomas 62 squamous cell carcinoma 62 lymph node metastases 62 papillary 62 metastatic prostate cancer 62 breast tumors 62 nonmelanoma skin cancers 62 PCNSL 62 colorectal polyps 62 lung tumors 62 synovial sarcoma 62 MGUS 62 invasive carcinoma 62 cervical carcinoma 62 cutaneous melanoma 62 melanomas 62 malignant lesions 62 gastrointestinal stromal tumor 62 pancreatic adenocarcinoma 62 prostate cancer 62 metastatic lesions 62 serous ovarian cancer 62 neuroendocrine tumors 62 lung cancers 62 adenocarcinomas 62 gastric adenocarcinoma 62 squamous cell cancers 62 urothelial carcinoma 61 colon cancers 61 leiomyosarcoma 61 thyroid nodules 61 renal cell carcinoma 61 invasive ductal 61 fibroadenomas 61 renal carcinoma 61 glioblastoma 61 Testicular cancer 61 cancer 61 benign polyps 61 basal cell 61 mesotheliomas 61 uveal melanoma 61 ovarian cancer 61 neoplasias 61 osteosarcomas 61 neoplastic lesions 61 breast carcinoma 61 squamous cell carcinomas 61 carcinoid 61 malignant transformation 61 malignant pleural mesothelioma 61 adenomas 61 node metastases 61 prostate tumor 61 renal tumors 61 pre cancerous lesion 61 breast lesions 60 gastric atrophy 60 grade gliomas 60 HNSCC 60 ductal cancer 60 bowel cancers 60 nasopharyngeal carcinoma 60 Barrett esophagus 60 atypical hyperplasia 60 esophageal adenocarcinoma 60 esophageal cancers 60 angiosarcoma 60 CaP 60 pancreatic tumor 60 GIST tumors 60 neoplastic 60 liver metastasis 60 MALT lymphoma 60 differentiated thyroid 60 gliomas 60 Carcinoma 60 prostate cancer PCa 60 lung nodules 60 soft tissue sarcomas 60 hepatocellular carcinoma HCC 60 metastatic tumors 60 seminoma 60 invasive breast cancer 60 histologic subtype 60 malignant melanoma 60 intestinal metaplasia 60 atypia 60 sarcomatoid 60 premalignant 60 prostate carcinoma 60 lymphoma 60 follicular lymphoma 60 cell carcinoma 60 rectal cancers 60 basal cell carcinoma BCC 59 lymphatic tissue 59 sarcomas 59 acute myelogenous leukemia AML 59 basal cell carcinomas 59 epithelial ovarian 59 CMV infection 59 GBM tumors 59 ALCL 59 curable cancers 59 metastatic cancers 59 Bladder cancer 59 meningiomas 59 prostate tumors 59 operable breast cancer 59 paraganglioma 59 pleural mesothelioma 59 cervical lesions 59 bladder tumors 59 colorectal cancer CRC 59 Gastric cancer 59 biochemical recurrence 59 medulloblastoma 59 testicular cancers 59 Non Hodgkin lymphoma 59 ductal 59 axillary lymph nodes 59 lung cancer 59 epithelial ovarian cancer 59 mucinous 59 medullary thyroid cancer 59 epithelial tumors 59 pheochromocytoma 59 colon cancer 59 pre cancerous polyps 59 squamous cell cancer 59 neuroendocrine carcinoma 59 liver cancer 59 advanced adenoma 59 liposarcoma 59 neuroblastomas 59 BRCA mutations 59 thyroid nodule 59 hyperplastic 59 proximal colon 59 pre malignant lesions 59 disease 59 Cholangiocarcinoma 59 extracapsular extension 59 VUR 59 Follicular lymphoma 59 systemic scleroderma 59 nonmelanoma skin cancer 59 Basal cell carcinoma 59 histologically 59 axillary dissection 59 metachronous 59 pleomorphic 58 thymoma 58 situ DCIS 58 grade cervical intraepithelial 58 nodular melanoma 58 rectal cancer 58 alveolar rhabdomyosarcoma 58 malignant prostate 58 pre cancerous lesions 58 lymph node involvement 58 locoregional recurrence 58 choriocarcinoma 58 astrocytoma 58 grade dysplasia 58 radical prostatectomy RP 58 chlamydial infection 58 liver metastases 58 malignant neoplasm 58 Hurthle cell 58 paragangliomas 58 lobular cancer 58 hamartomas 58 cancerous 58 leukemia ALL 58 ASCUS 58 incidentalomas 58 colorectal adenocarcinoma 58 pancreatic tumors 58 tumor metastases 58 cystectomy 58 tumoral 58 papillary carcinoma 58 hyperplasia 58 occult metastases 58 benign breast 58 transitional cell carcinoma 58 pre cancerous growths 58 supratentorial 58 papillary thyroid cancer 58 neuroblastoma tumors 58 gynecologic malignancy 58 malignant neoplasms 58 lymph node metastasis 58 pelvic lymph nodes 58 Helicobacter pylori infection 58 bladder cancer 58 PNET 58 basal cell cancers 58 axillary lymph node 58 adenoid cystic carcinoma 58 squamous cell carcinoma SCC 58 adrenal masses 58 gastric cardia 58 cell carcinomas 58 underarm lymph nodes 58 fibroadenoma 58 brain metastases 57 hyperplastic polyps 57 carcinoid tumors 57 sentinel node 57 Wilms tumor 57 papillary thyroid carcinoma 57 pelvic lymphadenectomy 57 pre cancerous 57 NAFLD 57 colorectal neoplasms 57 pancreatic carcinoma 57 medulloblastomas 57 pathologic 57 peritoneal carcinomatosis 57 lymph nodes 57 adenomatous polyp 57 cancerous polyps 57 brain tumor glioblastoma multiforme 57 Metastatic melanoma 57 pulmonary metastases 57 polyps 57 advanced adenomas 57 skin cancers 57 myelodysplastic syndrome MDS 57 Rectal cancer 57 basal cell cancer 57 Thyroid cancer 57 Glioblastoma 57 ependymoma 57 squamous cell 57 pituitary adenomas 57 cytoreductive surgery 57 seminomas 57 vulvar intraepithelial neoplasia 57 ovarian carcinoma 57 dysplasia 57 cervical lymph nodes 57 Malignant tumors 57 nonalcoholic steatohepatitis NASH 57 situ LCIS 57 contralateral breast 57 precancerous cells 57 benign lesions 57 lesions 57 histological subtype 57 APOL1 57 malignant pancreatic 57 nodal metastases 57 primitive neuroectodermal tumor 57 MYCN amplification 57 axillary node dissection 57 thyroid carcinoma 57 melanoma lesions 57 colorectal gastric 57 esophagogastric junction 57 malignant melanomas 57 noncancerous cells 57 Kaposi sarcoma 57 leiomyoma 57 pCR 57 Lymph node 57 indolent lymphomas 57 PSADT 57 endometrial carcinoma 57 nodal metastasis 57 postoperative pathology 57 Papillary 57 testicular tumors 57 lymph node 57 locoregional 57 nonsmall cell lung cancer 57 sentinel nodes 57 Ovarian cancer 57 gastrointestinal cancers 57 astrocytomas 57 malignant lesion 57 teratoma 57 aortic dissections 57 Metastatic breast cancer 57 neurofibroma 57 neoadjuvant chemotherapy 57 thyroid cancers 57 CIN3 56 cholangiocarcinoma 56 metastatic tumor 56 metastatic malignant melanoma 56 molecular abnormalities 56 malignant fibrous histiocytoma 56 bronchogenic carcinoma 56 ovarian tumor 56 CMV disease 56 lymphocytic 56 mammary cancers 56 carcinoids 56 lobular breast cancer 56 basal cell carcinoma 56 lesion 56 colon tumors 56 metastasise 56 DCIS lesions 56 squamous carcinoma 56 colorectal adenomas 56 poorer prognosis 56 endometrial cancer 56 cytologically 56 gastric carcinoma 56 fibrosis 56 carcinoid cancer 56 hormone refractory 56 histologic 56 peritoneal cancer 56 Endometrial cancer 56 embryonal rhabdomyosarcoma 56 adjuvant therapy 56 polyp recurrence 56 ductal breast cancer 56 de ath 56 meningioma 56 chronic HBV infection 56 metastatic bladder 56 axillary nodes 56 BRCA mutation 56 urothelial cancer 56 glioblastoma tumors 56 neoadjuvant therapy 56 colorectal polyp 56 pancreatic endocrine 56 dysplastic 56 HbF 56 endometrioid 56 lung adenocarcinomas 56 thyrotoxicosis 56 Glioblastoma multiforme GBM 56 breast endometrial 56 Stomach cancer 56 chondrosarcoma 56 cancerous lesions 56 EBV infection 56 Epstein Barr virus EBV 56 ccRCC 56 colon polyps 56 solid tumors 56 metastatic lung cancer 56 Polycythemia vera 56 lipomas 56 metastatic melanoma 56 histopathologic examination 56 precancerous lesion 56 untreated celiac disease 56 neuroblastoma tumor 56 Melanomas 56 micrometastasis 56 bone metastases 56 gynecologic cancers 56 cancer metastasizes 56 Acute myeloid leukemia 56 lymphoid 56 Hepatocellular Carcinoma HCC 56 pancreatic NET 56 cervical intraepithelial neoplasia 56 acute leukemias 56 malignant lymphoma 55 Squamous cell carcinoma 55 precancerous cervical lesions 55 biopsy 55 involution 55 atherosclerotic disease 55 Acute lymphoblastic leukemia 55 Basal cell 55 HER2 positive breast cancer 55 Hepatocellular carcinoma 55 lymphocytosis 55 mammary tumors 55 periodontitis 55 benign proliferative breast 55 cervical neoplasia 55 endometrial hyperplasia 55 Renal cell carcinoma 55 lobular carcinomas 55 breast cancer 55 EUS FNA 55 castration resistant prostate cancer 55 polyp 55 epithelioid 55 thymic carcinoma 55 cervical dysplasia 55 Tumours 55 malignant tissue 55 laryngeal cancer 55 hepatocellular cancer 55 precancerous 55 leukaemias 55 skeletal metastases 55 leiomyomas 55 invasive ductal carcinoma 55 prostate cancer CRPC 55 fallopian tube carcinoma 55 hematuria 55 genetic alteration 55 Esophageal cancer 55 cell lymphomas 55 HGPIN 55 pancreatic 55 pancreatic cancer 55 SLNB 55 rebleeding 55 melanoma tumors 55 squamous 55 precancerous cervical 55 endocrine tumors 55 myeloproliferative disorder 55 cisplatin resistant 55 NSCLC 55 genetic aberrations 55 EGFR mutation 55 eosinophilic 55 GIST 55 malignant phenotype 55 ascites 55 squamous cell lung cancer 55 mycosis fungoides 55 acute GvHD 55 hepatic fibrosis 55 Non Hodgkins lymphoma 55 HER2 overexpression 55 cyclin E 55 osteopetrosis 55 Prostate cancer 55 oesophageal adenocarcinoma 55 ovarian malignancy 55 p# mutations 55 Brain metastases 55 NMIBC 55 pituitary tumors 55 non Hodgkin lymphoma 55 varices 55 acute aortic dissection 55 chromosomal mutations 55 uterine cancers 55 Gliomas 55 sentinel lymph node 55 Osteosarcoma 55 esophageal cancer 55 molecular subtypes 55 lung metastasis 55 lymphadenopathy 55 varicocele 55 precancerous condition 55 EGFR inhibitors 55 Pancreatic cancer 55 familial ALS 55 atrophic gastritis 55 contralateral breast cancer 55 lung metastases 55 transurethral resection 55 chromosomal rearrangement 55 precancerous lesions 55 antitumor effect 55 total thyroidectomy 55 esophageal squamous cell carcinoma 55 Candida infection 55 nonmalignant 55 Colorectal cancers 55 CIN2 + 55 Malignant melanoma 55 surgical biopsy 55 gynecologic cancer 55 hypersensitivity reaction 55 benign tumors 55 hamartoma 55 endometrial 55 metastatic basal cell 55 lymphovascular invasion 55 cirrhotic liver 55 nonmetastatic 55 Adjuvant chemotherapy 55 cancerdefine 55 pheochromocytomas 55 brain tumors 55 malignant polyps 54 epithelial cancers 54 lymphadenectomy 54 dysplastic lesions 54 benign growths 54 HER2 positive cancers 54 cancerous growths 54 chromosomal aberrations 54 thromboembolic events 54 spontaneous remission 54 prostate tissue 54 precancers 54 invasive cervical cancer 54 anal lesions 54 Glioblastoma multiforme 54 BRCA1 mutations 54 Glioblastoma Multiforme GBM 54 Barrett esophagus BE 54 oesophageal cancer 54 liver fibrosis 54 axillary node 54 WT1 54 glioma 54 calculi 54 leukaemic stem cells 54 noncancerous 54 metastatic colon cancer 54 neuroendocrine cancers 54 basal cells 54 prostate pancreatic 54 breast cancer metastasis 54 FSGS 54 Carcinoid tumors 54 breast cancer recurrence 54 gastrointestinal stromal tumors 54 Benign tumors 54 recurrent glioblastoma multiforme GBM 54 #.#ng/ml 54 BRCA deficient 54 stage IIIA 54 prostate 54 thyroglobulin 54 HPV infection 54 mediastinal 54 Synovial sarcoma 54 leukoencephalopathy 54 osteosarcoma 54 tumor cells 54 BRAF gene 54 sentinel lymph node biopsy 54 adenomatous 54 non Hodgkin lymphomas 54 BRCA2 mutations 54 DIPG 54 cystic lesions 54 CIN3 + 54 undergoing radical prostatectomy 54 malignant tumor 54 chronic GVHD 54 polypoid 54 rectal carcinoma 54 HCV infection 54 Burkitt lymphoma 54 prophylactic cranial irradiation 54 HBV infection 54 radiochemotherapy 54 ependymomas 54 parathyroid carcinoma 54 uterine cancer 54 TMEM density 54 HPV infections 54 lung carcinomas 54 precancerous polyp 54 nephrectomy 54 thromboembolic disease 54 oncoprotein 54 histopathologic 54 mutant p# 54 CLL cells 54 oligodendroglioma 54 Adenomas 54 leukemia AML 54 familial pancreatic cancer 54 intestinal polyps 54 Hepatocellular carcinoma HCC 54 anti angiogenic therapy 54 microalbuminuria 54 metastatic ovarian cancer 54 idiopathic PAH 54 sporadic ALS 54 lymphocytic leukemia 54 prognostic indicator 54 H pylori 54 radical nephrectomy 54 thrombotic complications 54 hematopoietic cancers 54 esophagectomy 54 precancer 54 osteochondroma 54 metastatic melanomas 54 Chronic lymphocytic leukemia 54 metastatic breast cancer 54 hydronephrosis 54 adrenalectomy 54 smoldering myeloma 54 desmoid tumor 54 hepatocellular carcinomas 54 multiple myeloma 54 Metastatic 54 cancerous cells 54 ductal carcinoma 54 T1a 54 Sjögren syndrome 54 herpes simplex encephalitis 54 malignant cells 54 BRAF mutations 54 microscopic hematuria 54 metastatic lesion 54 lymphoproliferative disorders 54 malignant gliomas 54 follicular thyroid cancer 54 cancerous tumors 54 amyloid deposits 54 uterine cervix 54 pulmonary emboli 54 Malignant 54 resected 54 Radical prostatectomy 54 Rhabdomyosarcoma 54 polyps growths 54 lymphoblastic lymphoma 53 tumor subtypes 53 resectable 53 cancerous polyp 53 NP CRNs 53 indolent NHL 53 Barrett mucosa 53 myeloma cells 53 Hashimoto thyroiditis 53 metastatic RCC 53 sCJD 53 neoplastic cells 53 activating mutations 53 clinically detectable 53 orchiectomy 53 cancerous enlargement 53 heterotopic ossification 53 rhabdomyosarcoma 53 mucosal lesions 53 DLBCL 53 curability 53 cranial irradiation 53 metaplasia 53 basal cell nevus syndrome 53 ovarian 53 indolent lymphoma 53 Colorectal cancer 53 oral squamous cell 53 melanocytic 53 orchitis 53 gastrointestinal stromal tumor GIST 53 papillary renal cell carcinoma 53 Necrotizing fasciitis 53 malperfusion 53 grade serous ovarian 53 ductal carcinomas 53 wedge resection 53 EGFR mutations 53 esophageal tumors 53 pre cancerous cells 53 Malignant mesothelioma 53 schwannoma 53 esophageal carcinoma 53 perioperative complications 53 oncogenic HPV types 53 pancreatic cysts 53 Glioblastomas 53 mosaicism 53 curative resection 53 splenic 53 SSc 53 hypercalcemia 53 EGFRvIII 53 Wilms tumors 53 anal cancers 53 ALND 53 advanced neoplasia 53 intraductal 53 graft dysfunction 53 lymph node dissection 53 radiographic findings 53 familial adenomatous polyposis 53 acute lymphoblastic 53 keloid 53 H. pylori infection 53 idiopathic myelofibrosis 53 HER2 positive 53 myeloproliferative diseases 53 lymph node removal 53 mutated KRAS gene 53 ARVD 53 atherosclerotic lesions 53 metastatic renal cell carcinoma 53 Recurrences 53 tumor progression 53 postoperative pulmonary 53 androgen deprivation 53 recurrent NSCLC 53 p# mutation 53 nonmelanoma 53 malignant brain 53 malignant ovarian 53 mutation 53 serum PSA 53 Sezary syndrome 53 gynecological cancers 53 benign noncancerous 53 KRAS mutation 53 neurodegenerative disorder 53 MMP9 53 atypical ductal hyperplasia 53 clinicopathologic 53 glioma cells 53 herpes infection 53 noncancerous tumors 53 glioblastoma multiforme 53 pathologic fractures 53 chemosensitivity 53 aneurysmal bone cyst 53 B7 H3 53 colorectal adenoma 53 papillomas 53 neurosyphilis 53 Uterine fibroids 53 Male pattern baldness 53 subclinical atherosclerosis 53 sentinel lymph nodes 53 K ras mutations 53 acute rheumatic fever 53 percutaneous biopsy 53 varicoceles 53 lymphoproliferative disorder 53 hereditary breast cancer 53 schwannomas 53 aerodigestive tract 53 diabetic nephropathy 53 desmoplastic 53 chromosomal instability 53 colorectal 53 lymphoid cells 53 immunodeficiency 53 anti angiogenic drugs 53 axillary 53 prognostic marker 53 TMPRSS2 ERG fusion 53 NF1 53 pulmonary metastasis 53 grade glioma 53 monoclonal gammopathy 53 aneuploid cells 53 ventricular dysfunction 53 pseudotumor cerebri 53 penetrance 53 squamous cell skin 53 excisional biopsy 53 neurofibromas 53 PTLD 53 S. aureus infections 53 polypoid lesions 53 nasopharyngeal carcinoma NPC 53 BRAF V#E 53 carotid plaques 53 axillary lymph node dissection 53 biochemical relapse 53 autoantibodies 53 Adenocarcinoma 53 gastric lymphoma 53 pulmonary nodules 53 lung adenocarcinoma 53 fibrocystic disease 53 chemoradiotherapy 53 pT2 53 HER2 negative 53 tonsillar 53 testis 53 cytoreduction 53 oncogenic mutations 53 Cancerous cells 53 colectomy 53 oligodendrogliomas 53 subclinical disease 53 myeloid 53 elevated CRP 52 small lymphocytic lymphoma 52 pathogenic mutations 52 Pleural mesothelioma 52 candidemia 52 subtype 52 etiologic agent 52 genetic abnormalities 52 FDG uptake 52 EBRT 52 bony metastases 52 POAG 52 tumor histology 52 allogeneic HSCT 52 disease progression 52 Sentinel node biopsy 52 Inflammatory breast cancer 52 amyloid deposition 52 lymphoid tissue 52 leukemic stem cells 52 CMV infections 52 bile duct cancers 52 BRAF mutation 52 cancerous tissue 52 adjuvant radiotherapy 52 ductal lobular 52 lichen planus 52 curative therapy 52 extramedullary 52 Basal cell carcinomas 52 androgen receptor AR 52 spontaneous regression 52 myoma 52 carotid plaque 52 FGFR2 52 chronic myelogenous leukemia CML 52 pancreatic lung 52 LVNC 52 carcinoma HCC 52 transfusion syndrome 52 lipoma 52 proliferative diabetic retinopathy 52 nephropathy 52 adrenocortical cancer 52 castrate resistant 52 PSA nadir 52 prostate carcinomas 52 clinically insignificant 52 metastatic lymph nodes 52 pT3 52 epithelial cell 52 nephrogenic 52 polycythemia vera 52 Cryptococcus neoformans 52 Heavy menstrual bleeding 52 prognostic significance 52 ductal adenocarcinoma 52 Wegener granulomatosis 52 Uterine cancer 52 choroidal neovascularization 52 immunocompetent 52 BCCs 52 submucosa 52 acute promyelocytic leukemia 52 Thyroid nodules 52 chromophobe 52 esophagitis 52 Lung cancer 52 cholelithiasis 52 BRCA mutation carriers 52 seminal vesicle invasion 52 essential thrombocythemia 52 NOTCH1 52 glandular tissue 52 pituitary adenoma 52 preoperative chemotherapy 52 estrogen receptor positive 52 gastroesophageal junction 52 cell lymphoma ALCL 52 carotid stenosis 52 Metastases 52 endosonography 52 CLL 52 retinoblastoma 52 mammographically 52 biliary tract cancer 52 gallstone disease 52 asymptomatic 52 fibrocystic 52 oophorectomy 52 N. gonorrhoeae 52 invasive lobular 52 Gorlin syndrome 52 morphologic 52 parenchyma 52 metastatic adenocarcinoma 52 KRAS wild 52 biliary strictures 52 chemoradiation 52 T1c 52 infantile hemangiomas 52 villous 52 prostate specific 52 BRCA2 mutation carriers 52 fibromatosis 52 aneurysm rupture 52 fibrous dysplasia 52 retroperitoneal 52 BRAF V#E mutation 52 carcinoma HNSCC 52 neovascularization 52 uterine tumors 52 renal transplantation 52 Polyps 52 papillary RCC 52 myeloproliferative neoplasms 52 gene rearrangements 52 precancerous colon polyps 52 familial adenomatous polyposis FAP 52 tumors GIST 52 TP# mutation 52 proliferative disorders 52 nonseminoma 52 Hurler syndrome 52 nodule 52 melanocytic nevi 52 periodontal bacteria 52 cervical uterine 52 renal scarring 52 presymptomatic 52 diffuse intrinsic pontine glioma 52 AA amyloidosis 52 prostate biopsy 52 Colorectal cancer CRC 52 node metastasis 52 testicular germ cell 52 cryptogenic stroke 52 benign polyp 52 metastatic kidney 52 recurrent ovarian 52 unresectable tumors 52 colonic polyps 52 infectious mononucleosis 52 histological diagnosis 52 cardiac dysfunction 52 relapsing remitting 52 Waldenstrom macroglobulinemia 52 infiltrating ductal carcinoma 52 ALK mutations 52 hematologic malignancy 52 extrahepatic 52 LRP5 52 Prognostic factors 52 germline mutations 52 inherited neurodegenerative disorder 52 intraoperative complications 52 leukemic cells 52 Her2 52 dyskeratosis congenita 52 geographic atrophy 52 metastatic prostate 52 cervical cancer 52 allograft rejection 52 cutaneous squamous cell carcinoma